🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jessica K. Altman

Northwestern University

ORCID: 0000-0003-1987-1896

Also affiliated with Robert H. Lurie Comprehensive Cancer Center of Northwestern University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 14 papers. Top paper: “Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study”.

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

The Lancet(2020)10.1016/s0140-6736(20)31187-9

N/A

11.9DataRank · unranked

1804 citations

Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein, Donna R. Rivera +95 more

A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating agents

Annals of Hematology(2023)10.1007/s00277-023-05552-4

N/A

0.726DataRank · unranked

23 citations

Rory M. Shallis, Elad Sharon, Silvia Park, Rahul Ramaswamy, Caroline E. Roe +18 more

A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance

Cancer Cell(2020)10.1016/j.ccell.2020.10.022

N/A

0.529DataRank · unranked

33 citations

David M. Aboulafia, Melissa Accordino, Jared D. Acoba, Manmeet S. Ahluwalia, Syed A. Ahmad +95 more

Patient‐reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemia

Cancer(2023)10.1002/cncr.35021

N/A

0.528DataRank · unranked

18 citations

Francesco Cottone, Betina R. Yanez, Vamsi Kota, Fausto Castagnetti, Giovanni Caocci +18 more

Adverse Events During Hematopoietic Stem Cell Infusion: Analysis of the Infusion Product

Clinical Lymphoma Myeloma and Leukemia(2015)10.1016/j.clml.2015.08.085

N/A

0.470DataRank · unranked

22 citations

Marcelo Villa, Irene B. Helenowski, Mehboob Merchant, Borko D. Jovanovic, Richard Meagher +8 more

TP53‐altered acute myeloid leukemia and myelodysplastic syndrome with excess blasts should be approached as a single entity

Cancer(2022)10.1002/cncr.34535

N/A

0.434DataRank · unranked

17 citations

Naval Daver, Jessica K. Altman, Robert P. Hasserjian, Hagop M. Kantarjian, Uwe Platzbecker +5 more

Inhibitory effects of Tomivosertib in acute myeloid leukemia

Oncotarget(2021)10.18632/oncotarget.27952

N/A

0.360DataRank · unranked

10 citations

Gavin T. Blyth, Alain Mina, Ewa M. Kościuczuk, Blazej Dolniak, Shira Dinner +6 more

Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failure

Blood Advances(2025)10.1182/bloodadvances.2025018178

N/A

0.357DataRank · unranked

7 citations

Brian Ball, Yasmin Abaza, Jessica K. Altman, Rahul Thakur, Moiez Ali +12 more

PRL2 Phosphatase Promotes Oncogenic KIT Signaling in Leukemia Cells through Modulating CBL Phosphorylation

Molecular Cancer Research(2023)10.1158/1541-7786.mcr-23-0115

N/A

0.269DataRank · unranked

5 citations

Yunpeng Bai, Michihiro Kobayashi, Shiyu Xiao, Sergio Barajas, Wenjie Cai +25 more

Targeting scavenger receptor class B type 1 with a bioinspired ligand induces apoptosis or ferroptosis in AML

Blood Neoplasia(2025)10.1016/j.bneo.2025.100122

N/A

0DataRank · unranked

1 citations

Jonathan S. Rink, Eva Yang, Sara Small, Jessica J. Gerber, Taylor Zak +6 more

Data from Dual mTORC2/mTORC1 Targeting Results in Potent Suppressive Effects on Acute Myeloid Leukemia (AML) Progenitors

(2023)10.1158/1078-0432.c.6519228

N/A

0DataRank · unranked

0 citations

Antonella Sassano, Surinder Kaur, Heather Glaser, Barbara Kroczyńska, Amanda J. Redig +4 more

Data from Dual mTORC2/mTORC1 Targeting Results in Potent Suppressive Effects on Acute Myeloid Leukemia (AML) Progenitors

(2023)10.1158/1078-0432.c.6519228.v1

N/A

0DataRank · unranked

0 citations

Antonella Sassano, Surinder Kaur, Heather Glaser, Barbara Kroczyńska, Amanda J. Redig +4 more

PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371

Blood(2022)10.1182/blood.2022016580

N/A

0DataRank · unranked

16 citations

Yunpeng Bai, Michihiro Kobayashi, Shiyu Xiao, Wenjie Cai, Sergio Barajas +21 more

Identifying eligibility criteria that perpetuate race/ethnic disparities in acute myeloid leukemia (AML) clinical trial participation.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.1589

N/A

0DataRank · unranked

3 citations

Yating Wang, Ivy Abraham, Anand Patel, Sarah Monick, Garth H. Rauscher +15 more